Cardiovascular Health and Medications

Vascular Health Issues

  • Stiffening and hardening of blood vessels is a major health concern.

    • Problems associated with stiffening:

      • Reduced Blood Pressure: A narrower blood vessel increases blood pressure.

      • Risk of Clots: Atherosclerosis can cause plaque to break off, leading to blocked blood flow and potential medical emergencies: Myocardial Infarction (MI), Stroke, Pulmonary Embolism (PE).

      • Vessel Damage: Thicker, stiffer vessel walls are less compliant, making them more susceptible to damage.

Angina

  • Definition: Chest pain caused by insufficient oxygen supply to meet the heart's demand; not the same as pain from an MI.

  • Key Terms:

    • Hypoxia: Reduced oxygen supply.

    • Myocardial Infarction (MI): Death of myocardial tissue due to prolonged ischemia.

  • **Angina Types:

    • Stable Angina: Predictable chest pain with exertion; treated with rest.

    • Variant Angina: Caused by coronary artery spasm; can occur at rest.

    • Unstable Angina: Occurs unpredictably and is a precursor to MI.

Lipids and Cholesterol

  • Types of Cholesterol:

    • HDL (High-Density Lipoprotein): Known as 'good' cholesterol; carries cholesterol back to the liver.

    • LDL (Low-Density Lipoprotein): Known as 'bad' cholesterol; contributes to plaque buildup in arteries.

  • Focus on decreasing lipids as they affect plaque development in arteries.

  • Food Sources:

    • High Cholesterol Foods: Eggs, shrimp.

    • Healthy Fats: Salmon (contains omega-3, beneficial despite some cholesterol).

  • Monitoring: Educate patients on checking their lipid levels and understanding food labels for cholesterol content.

Medications for Lipid Management

  • Statins:

    • Example: Atorvastatin, a first-line medication for lowering LDL.

    • Mechanism of action: Inhibits liver cholesterol synthesis.

    • Side Effects: Rhabdomyolysis (muscle breakdown), potential kidney injury from myoglobin accumulation.

    • Monitoring: Check creatinine, BUN, and GFR for renal function.

  • Bile Acid Sequestrants:

    • Example: Cholestyramine.

    • Mechanism: Prevents GI absorption of lipids, excreted through feces.

    • Side Effects: Constipation; patient education on hydration, fiber intake, and bowel movement timing is crucial.

  • Zetia (Ezetimibe):

    • Blocks cholesterol absorption in the intestine.

    • Used in conjunction with statins; liver function tests must be monitored due to hepatotoxic risk.

  • Fibrates:

    • Reduces triglycerides and increases HDL.

    • Watch for potential drug interactions with anticoagulants like warfarin; increased bleeding risk and gallstones.

Nursing Responsibilities for Lipid Management

  • Assess lipid panels and liver function tests regularly.

  • Education on lifestyle changes, including diet and exercise.

  • Monitor any signs indicating rhabdomyolysis or liver impairment.

Myocardial Oxygen Demand and Angina Management: Medications

  • Vasodilators (Nitroglycerin):

    • Decreases myocardial oxygen demand and increases supply through vasodilation.

    • Routes: Sublingual (quick onset), topical, or IV in acute settings.

    • Key education on administration and storage.

  • Beta Blockers:

    • Reduce heart rate and contractility, lowering oxygen demand.

    • Commonly prescribed post-MI to prevent cardiac remodeling.

  • Calcium Channel Blockers (CCBs):

    • Reduce heart rate and afterload; often used for angina and certain dysrhythmias.

  • Cautions regarding combining therapies to prevent reflex tachycardia and potential hypotension.

Anticoagulants and Management of Clots

  • Anticoagulants: Used primarily to prevent clots from forming rather than breaking down existing clots.

    • Types: Heparin, Warfarin, Low Molecular Weight Heparin (e.g., Enoxaparin), direct thrombin inhibitors (Dabigatran), and factor X inhibitors (e.g., Apixaban).

    • Monitoring: PTT for heparin; INR for warfarin; clinical evaluation of bleeding risks.

  • Education for Patients:

    • Awareness of bleeding risks, symptoms to report, and lifestyle modifications to minimize risks.

    • Discuss interactions with vitamin K foods for those on warfarin.

Thrombolytics (Clot Busters)

  • Alteplase (tPA): A thrombolytic agent to dissolve clots within a certain timeframe post-symptom onset.

    • Administration Timing: Ideally within 3-4 hours; effectiveness diminishes over time.

    • Contraindications: Never administer if there is recent bleeding or bleeding history.

Surgical Interventions for Angina and Ischemia

  • Percutaneous Coronary Intervention (PCI): Techniques to open blocked coronary arteries, may include stenting.

  • Coronary Artery Bypass Grafting (CABG): A surgical procedure that re-routes blood around a blockage using a vessel from another body part.

Summary of Key Concepts:

  • Management of lipid levels is critical for heart health, especially in preventing ischemic conditions.

  • Angina should be promptly identified and managed to prevent the progression to MI.

  • Anticoagulants play a significant role in preventing thrombotic events, with careful monitoring required.